Medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as preparation method, quality control method and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the direction of pharmaceutical formulations, medical preparations containing active ingredients, antiviral agents, etc., can solve problems such as the curative effect needs to be improved
Active Publication Date: 2012-08-22
GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
View PDF1 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, its efficacy st
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0043] The preparation method of above-mentioned pharmaceutical composition, comprises the steps:
[0044] 1) Take the crude drug, decoct it with water, filter, and take the filtrate;
[0045] 2) centrifuging the filtrate, taking the supernatant, concentrating, and extracting the concentrate with water;
[0046] 3) adding ethanol to the concentrated water extract, stirring, standing still, and then centrifuging, taking the supernatant, removing ethanol, and obtaining the ethanol extract;
[0047] 4) Prepare the pharmaceutical preparation by combining the alcohol extract and other acceptable pharmaceutical excipients.
[0048] Furthermore, its preparation method includes the following steps:
[0049] 1) Take the raw material drug, add water to decoct 3 times, add 20 times the amount of water each time, decoct for 2 hours, let cool, filter, and combine the filtrate;
[0050] 2) Centrifuge the filtrate, take the supernatant and concentrate it to the weight of the raw material ...
Embodiment 1
[0072] Raw material composition:
[0073] 25 parts of cooked aconite, 12.5 parts of epimedium, 12.5 parts of dried ginger, 12.5 parts of licorice, 7.82 parts of red ginseng, 7.81 parts of poria cocos, 7.81 parts of knotweed, 7.81 parts of salvia miltiorrhiza, 3.75 parts of Phellodendron phellodendri, and 2.5 parts of skullcap.
Embodiment 2
[0075] Raw material composition:
[0076] 20 parts of cooked aconite, 14 parts of epimedium, 15 parts of dried ginger, 10 parts of licorice, 10 parts of red ginseng, 12 parts of poria cocos, 6 parts of knotweed, 10 parts of salvia miltiorrhiza, 5 parts of Phellodendron phellodendri, and 3 parts of skullcap.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a medicinal composition for treating acquired immune deficiency syndrome (Aids) as well as a preparation method, quality control method and application of the medicinal composition. The raw materials of the medicinal composition comprise cooked monkshood, herba epimedii, dried ginger, liquorice, ginseng, the root of red-rooted salvia, giant knot weed, Poria cocos, golden cypress and Scutellaria baicalensis. Experimental data indicate that the medicinal composition preparation disclosed by the invention has Aids treating function on Aids model monkeys derived from rhesus monkeys infected by monkey Aids Virus, based on the curative effect on the Aids monkey models adaptive to Aids animal models, the medicinal composition preparation has the application of treating human Aids; after being given to HIV infected persons or Aids patients, the medicinal composition preparation can relieve disease, i stabilize or improvethe CD4+T lymphocyte count level of the HIV infected persons or the Aids patients, relieve clinical clinical symptoms and improve survival quality.
Description
technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating AIDS. The invention also relates to a quality control method and use of the composition. Background technique [0002] AIDS is an acquired immunodeficiency syndrome caused by HIV infection. The clinical manifestations of different stages of HIV infection process and pathogenesis are complex and diverse, including fatal malignant tumors and various opportunistic infections that occur later. [0003] People generally enter the onset period after 7-12 years after being infected with HIV-1. According to the current standard of diagnosis and treatment, antiviral therapy is not recommended for HIV carriers who are asymptomatic and whose CD+ T cell count has not been greatly reduced (for example, still above 300 per microliter), otherwise it will cause patients and society Take the huge risk of inducing severe drug resistance. According to the ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more